Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?

ConclusionCompared to patients receiving AC, those receiving NAC do not start treatment sooner. In addition, patients receiving NAC do not complete treatment faster. Although there are clear indications for administering NAC vs AC, rapidity of treatment should not be considered a benefit of giving chemotherapy preoperatively.

Source: Cancer Medicine - February 28, 2020 Category: Cancer & Oncology Authors: Nicole M. Melchior, Darren B. Sachs, Gabrielle Gauvin, Cecilia Chang, Chihsiung E. Wang, Elin R. Sigurdson, John M. Daly, Allison A. Aggon, Shelly B. Hayes, Elias I. Obeid, Richard J. Bleicher Tags: ORIGINAL RESEARCH Source Type: research